| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/02/2006 | EP1685835A2 Long term administration of sub-therapeutic dose levels of pharmacologically active agents |
| 08/02/2006 | EP1685834A1 Use of pinolenic acid for the treatment of obesity |
| 08/02/2006 | EP1685833A1 Remedy for diabetes |
| 08/02/2006 | EP1685832A1 Nerve regeneration promoters |
| 08/02/2006 | EP1685831A1 Pharmaceutical polymer composition for oral controlled release delivery of terbutaline sulfate |
| 08/02/2006 | EP1685830A1 Plaster |
| 08/02/2006 | EP1685829A1 Use of (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol for treating inflammatory pain |
| 08/02/2006 | EP1685828A1 Solid pharmaceutical composition comprising tilidine hydrochloride |
| 08/02/2006 | EP1685822A1 Glucose absorption inhibitor and process for producing the same |
| 08/02/2006 | EP1685763A1 Synergism of GOS and polyfructose |
| 08/02/2006 | EP1685282A2 Crystal growth devices and systems, and methods for using same |
| 08/02/2006 | EP1685254A2 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 08/02/2006 | EP1685236A2 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
| 08/02/2006 | EP1685150A2 NOVEL 17beta HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS |
| 08/02/2006 | EP1685147A2 Modulation of sglt2 expression |
| 08/02/2006 | EP1685145A2 Glycomimetic antagonists for both e- and p-selectins |
| 08/02/2006 | EP1685142A1 Phosphinic acid derivatives, beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/02/2006 | EP1685140A1 Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same |
| 08/02/2006 | EP1685137A2 Particle-forming compositions containing fused pyrrolocarbazoles |
| 08/02/2006 | EP1685136A1 Use of thienopyrimidines |
| 08/02/2006 | EP1685135A1 Tetrahydro-furo¬3,4-d|dioxole compounds and compositions and method for inhibiting platelet aggregation |
| 08/02/2006 | EP1685131A1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 08/02/2006 | EP1685130A1 Polymorphs of 1-cyclopropyl-7-([s,s] - 2,8-diazadicyclo [4.3.0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof |
| 08/02/2006 | EP1685127A1 Heterocyclyl-substituted oxetanes for the treatment of proliferative or infectious diseases |
| 08/02/2006 | EP1685124A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 08/02/2006 | EP1685123A2 Substituted dihydroquinazolines ii |
| 08/02/2006 | EP1685121A1 Antidiabetic compounds comprising benzofuran and benzothiophene derivatives |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1685118A2 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 08/02/2006 | EP1685117A1 Fluorinated resorufin compounds and their application in detecting hydrogen peroxide |
| 08/02/2006 | EP1685116A1 Quinazoline derivatives |
| 08/02/2006 | EP1685115A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 08/02/2006 | EP1685114A2 Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines. |
| 08/02/2006 | EP1685113A1 Substituted pyrazoles as ppar agonists |
| 08/02/2006 | EP1685110A1 Octahydrophenanthrene hydrazide derivatives useful as glucocorticoid receptor modulators |
| 08/02/2006 | EP1685109A2 Amide compounds as ion channel ligands and uses thereof |
| 08/02/2006 | EP1685108A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 08/02/2006 | EP1685107A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 08/02/2006 | EP1685105A1 Allosteric modulators of metabotropic glutamate receptors |
| 08/02/2006 | EP1685103A1 3-aminopyrrolidone derivatives |
| 08/02/2006 | EP1685102A1 Melanocortin receptor agonists |
| 08/02/2006 | EP1685101A1 N-acylated-3-(benzoyl)-pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders. |
| 08/02/2006 | EP1685100A1 Novel 1, 3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 08/02/2006 | EP1685099A1 Crystalline forms of 1,24(s)-dihiyproxy vitamin d2 |
| 08/02/2006 | EP1685096A1 Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing the same |
| 08/02/2006 | EP1685090A1 Androgen receptor modulators |
| 08/02/2006 | EP1684851A1 Methods for preparing polymeric buffer formulations for electrotransport applications |
| 08/02/2006 | EP1684806A1 Compositions and methods of treatment using l-type calcium channel blockers and cholinesterase inhibitors |
| 08/02/2006 | EP1684787A1 Hepatitis c virus inhibitors |
| 08/02/2006 | EP1684784A2 Compositions of a cyclooxygenase-2 selective inhibitor and a neurotrophic factor-modulating agent for the treatment of central nervous system mediated disorders |
| 08/02/2006 | EP1684780A1 The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin |
| 08/02/2006 | EP1684779A1 Method for controlling angiogenesis in animals |
| 08/02/2006 | EP1684777A2 Effect of beta-glucan on stem cell recruitment and tissue repair |
| 08/02/2006 | EP1684776A1 Natural astaxanthin extract reduces dna oxidation |
| 08/02/2006 | EP1684774A2 STIMULATION OF HAIR GROWTH BY i GINKGO BILOBA /i FLAVANOIDS |
| 08/02/2006 | EP1684772A1 Therapeutic peg solution concentrate |
| 08/02/2006 | EP1684771A1 Composition and method |
| 08/02/2006 | EP1684770A1 Oligo-beta-(1,3)-glucan and monoclonal antibodies against cancer |
| 08/02/2006 | EP1684769A2 Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone |
| 08/02/2006 | EP1684768A2 Methods of treating eczema |
| 08/02/2006 | EP1684767A1 Soft steroid compositions for use in dry powder inhalers |
| 08/02/2006 | EP1684766A1 USE OF 3-AZA-1-OXA-DIBENZO i e,h /i AZULENES FOR TH E MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS |
| 08/02/2006 | EP1684765A1 Use of (2s, 3s) 2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol |
| 08/02/2006 | EP1684764A2 Methods for treating diseases and conditions with inverse agonists and for screening for agents acting as inverse agonists |
| 08/02/2006 | EP1684763A1 6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agent |
| 08/02/2006 | EP1684762A2 Urea derivatives as kinase modulators |
| 08/02/2006 | EP1684761A1 Method and composition for treatment or prophylaxis of amyloidosis disorders |
| 08/02/2006 | EP1684760A1 Method and composition for treatment of cutaneous lesions |
| 08/02/2006 | EP1684759A2 4-phenyl piperdine sulfonyl glycine transporter inhibitors |
| 08/02/2006 | EP1684758A2 Methods and compositions using thalidomide for the treatment and management of cancers and other diseases. |
| 08/02/2006 | EP1684757A1 Substituted piperidines for the treatment of metabolic syndrome |
| 08/02/2006 | EP1684756A1 Cytokine inhibitory drugs for treatment of macular degeneration |
| 08/02/2006 | EP1684755A1 Use of (+)-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dymethyl-pyridine-3,5-dicarboxylate in the treatment of memory disorders |
| 08/02/2006 | EP1684754A1 Hmg-coa reductase inhibitors and method |
| 08/02/2006 | EP1684753A2 Neuromuscular blocking agents and antagonists thereof |
| 08/02/2006 | EP1684752A1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists |
| 08/02/2006 | EP1684751A1 Use of 1-thia-dibenzo e,h azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 08/02/2006 | EP1684750A2 2-aminoaryloxazole compounds as tyrosine kinase inhibitors |
| 08/02/2006 | EP1684749A1 USE OF 1,3-DIAZA-DIBENZO[e,h] AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| 08/02/2006 | EP1684748A2 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline |
| 08/02/2006 | EP1684747A1 Bisindolyl maleimides useful for treating prostate cancer and akt-mediated diseases |
| 08/02/2006 | EP1684746A1 USE OF 1-AZA-DIBENZO[e,h]|AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| 08/02/2006 | EP1684745A2 Hepatitis c virus inhibitors |
| 08/02/2006 | EP1684744A2 Pyrrolidine and piperidine derivatives as factor xa inhibitors |
| 08/02/2006 | EP1684743A1 Composition and method for treating macular degeneration |
| 08/02/2006 | EP1684742A1 Use of 1-oxadibenzo e,h azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 08/02/2006 | EP1684741A2 Methods of using and compositions comprising pde4 modulators for the treatment and management of asbestos-related diseases and disorders |
| 08/02/2006 | EP1684740A1 Phenylpropanoic derivatives and compositions containing same, which stimulate libido and the associated physiological mechanisms |
| 08/02/2006 | EP1684739A1 Treatment and prevention of liver disease associated with parenteral nutrition (pn) |
| 08/02/2006 | EP1684738A1 Inhibitors of yeast filamentous growth and method of their manufacture |
| 08/02/2006 | EP1684737A1 Pharmaceutical composition containing guaiacol derivatives and syringol derivatives extracted from natural plant vinegar |
| 08/02/2006 | EP1684736A1 Dna damage repair inhibitors for treatment of cancer |
| 08/02/2006 | EP1684735A2 Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias |
| 08/02/2006 | EP1684734A2 Olanzapine containing transdermal drug delivery compositions |
| 08/02/2006 | EP1684732A2 Ibuprofen-containing soft gelatin capsules |
| 08/02/2006 | EP1684730A1 Pharmaceutical composition having a cationic excipient |
| 08/02/2006 | EP1684728A1 Non-effervescent form of sodium naproxen comprising i.a. sodium hydrogen carbonate |
| 08/02/2006 | EP1684727A1 Macromolecular drug complexes having improved stability and therapeutic use of the same |
| 08/02/2006 | EP1684725A1 Novel nimesulide compositions |
| 08/02/2006 | EP1684722A2 Medicamentously targeted local lipolysis |